Clinical Trial Update: Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for nab-paclitaxel + cisplatin + gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma (stages Phase 1/Phase 2; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Nab-Paclitaxel + Cisplatin + Gemcitabine

Snippet

Sponsor: Pancreatic Cancer Research Team | Conditions: Stage IV Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-29